+1 (704) 266-3234

Global Influenza Diagnostics Market Size, Status And Forecast 2021-2027

Published on: Nov 2021 | From USD $3500 | Published By: GIR JAPANESE | Number Of Pages: 105

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.

Market Analysis and Insights: Global Influenza Diagnostics Market
The global Influenza Diagnostics market size is projected to reach US$ 3374.9 million by 2027, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Diagnostics market.

Global Influenza Diagnostics Scope and Market Size
Influenza Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RIDT
RT-PCR
Cell Culture
Others

Segment by Application
Hospitals
POCT
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2016-2027)
2.2 Influenza Diagnostics Growth Trends by Regions
2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Diagnostics Industry Dynamic
2.3.1 Influenza Diagnostics Market Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027)

5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Influenza Diagnostics Market Size (2016-2027)
6.2 North America Influenza Diagnostics Market Size by Type
6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027)
6.3 North America Influenza Diagnostics Market Size by Application
6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027)
6.4 North America Influenza Diagnostics Market Size by Country
6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Influenza Diagnostics Market Size (2016-2027)
7.2 Europe Influenza Diagnostics Market Size by Type
7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027)
7.3 Europe Influenza Diagnostics Market Size by Application
7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027)
7.4 Europe Influenza Diagnostics Market Size by Country
7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Influenza Diagnostics Market Size by Type
8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Application
8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Diagnostics Market Size by Region
8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2016-2027)
9.2 Latin America Influenza Diagnostics Market Size by Type
9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Influenza Diagnostics Market Size by Application
9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Influenza Diagnostics Market Size by Country
9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Influenza Diagnostics Market Size by Type
10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Application
10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Diagnostics Market Size by Country
10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021)
11.12.5 SA Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RIDT
Table 3. Key Players of RT-PCR
Table 4. Key Players of Cell Culture
Table 5. Key Players of Others
Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Influenza Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Influenza Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Influenza Diagnostics Market Share by Regions (2022-2027)
Table 12. Influenza Diagnostics Market Trends
Table 13. Influenza Diagnostics Market Drivers
Table 14. Influenza Diagnostics Market Challenges
Table 15. Influenza Diagnostics Market Restraints
Table 16. Global Influenza Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Influenza Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020)
Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Diagnostics Product Solution and Service
Table 23. Date of Enter into Influenza Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Influenza Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Influenza Diagnostics Product
Table 66. BD Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 67. BD Recent Development
Table 68. Abbott (Include Alere) Company Details
Table 69. Abbott (Include Alere) Business Overview
Table 70. Abbott (Include Alere) Influenza Diagnostics Product
Table 71. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Abbott (Include Alere) Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Influenza Diagnostics Product
Table 76. Roche Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. SIEMENS Company Details
Table 79. SIEMENS Business Overview
Table 80. SIEMENS Influenza Diagnostics Product
Table 81. SIEMENS Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 82. SIEMENS Recent Development
Table 83. Analytik Jena Company Details
Table 84. Analytik Jena Business Overview
Table 85. Analytik Jena Influenza Diagnostics Product
Table 86. Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Analytik Jena Recent Development
Table 88. Quidel Company Details
Table 89. Quidel Business Overview
Table 90. Quidel Influenza Diagnostics Product
Table 91. Quidel Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Quidel Recent Development
Table 93. Thermo Fisher Company Details
Table 94. Thermo Fisher Business Overview
Table 95. Thermo Fisher Influenza Diagnostics Product
Table 96. Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Thermo Fisher Recent Development
Table 98. Meridian Bioscience Company Details
Table 99. Meridian Bioscience Business Overview
Table 100. Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Meridian Bioscience Recent Development
Table 102. BioMerieux Company Details
Table 103. BioMerieux Business Overview
Table 104. BioMerieux Influenza Diagnostics Product
Table 105. BioMerieux Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 106. BioMerieux Recent Development
Table 107. Sekisui Diagnostics Company Details
Table 108. Sekisui Diagnostics Business Overview
Table 109. Sekisui Diagnostics Influenza Diagnostics Product
Table 110. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Sekisui Diagnostics Recent Development
Table 112. Response Biomedical Company Details
Table 113. Response Biomedical Business Overview
Table 114. Response Biomedical Influenza Diagnostics Product
Table 115. Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Response Biomedical Recent Development
Table 117. SA Scientific Company Details
Table 118. SA Scientific Business Overview
Table 119. SA Scientific Influenza Diagnostics Product
Table 120. SA Scientific Revenue in Influenza Diagnostics Business (2016-2021) & (US$ Million)
Table 121. SA Scientific Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. RIDT Features
Figure 3. RT-PCR Features
Figure 4. Cell Culture Features
Figure 5. Others Features
Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. POCT Case Studies
Figure 9. Others Case Studies
Figure 10. Influenza Diagnostics Report Years Considered
Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Influenza Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Influenza Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Influenza Diagnostics Market Share by Players in 2020
Figure 16. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2020
Figure 18. Global Influenza Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Influenza Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Influenza Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Influenza Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Influenza Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Influenza Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Influenza Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Influenza Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Influenza Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Influenza Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Influenza Diagnostics Market Share by Region (2016-2027)
Figure 40. China Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Influenza Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Influenza Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Influenza Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Influenza Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Influenza Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Influenza Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. BD Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 60. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 62. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 63. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 64. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 65. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 66. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 67. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 68. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 69. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 70. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3500
USD $4500
USD $6000
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.